Scott A. Reines
Chief Medical Officer
Drug Development
Tetra Discovery Partners Inc.
United States of America
Biography
Dr. Scott A. Reines has broad drug development experience obtained as a senior executive in pharmaceutical R&D. As Senior Vice President for CNS, Pain, and Translational Medicine at Johnson & Johnson, he oversaw the development and approval of numerous medicines for the treatment of schizophrenia, Alzheimer’s disease, and the behavioral manifestations of autism. Prior to that, Dr. Reines served at Merck as Vice President, Clinical Research, with responsibilities for Psychopharmacology, Neuropharmacology, Gastroenterology, and Ophthalmology. While there, he oversaw the conduct of the first large, multicenter trial of a COX-2 inhibitor for prevention of Alzheimer’s disease. Dr. Reines earned a BS magna cum laude in chemistry from Cornell University, his PhD in bio/organic chemistry from Columbia University, and his MD from Albert Einstein College of Medicine. Following this he completed a psychiatric residency at Montefiore Hospital in New York City and obtained Board certification in psychiatry.
Research Interest
Psychopharmacology, Neuropharmacology, Gastroenterology, and Ophthalmology,Clinical
